Literature DB >> 17046006

Identification of an isomer impurity in piperaquine drug substance.

N Lindegårdh1, F Giorgi, B Galletti, M Di Mattia, M Quaglia, D Carnevale, N J White, A Mazzanti, N P J Day.   

Abstract

A significant contaminant of the antimalarial drug piperaquine (1,3-bis-[4-(7-chloroquinolyl-4)-piperazinyl-1]propane) has been identified using liquid chromatography-mass spectrometry (LC-MS) and 2D NMR spectroscopy (1H-1H COSY, 1H-13C HSQC, 1H-13C HMBC). The impurity was identified as the positional isomer 1-[(5-chloroquinolin-4)-piperazinyl]-3-[(7-chloroquinolin-4)-piperazinyl]propane. The impurity is formed because of contamination of batches of 4,7-dichloroquinoline (a precursor in the synthesis of piperaquine) with 4,5-dichloroquinoline. The amount of impurity (peak area impurity/peak area piperaquine using LC-UV at 347 nm) in old batches of piperaquine and in Artekin (the combination of dihydroartemisinin-piperaquine) ranged from 1.5 to 5%.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046006     DOI: 10.1016/j.chroma.2006.09.066

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  A Multidisciplinary Investigation to Determine the Structure and Source of Dimeric Impurities in AMG 517 Drug Substance.

Authors:  Maria Victoria Silva Elipe; Zhixin Jessica Tan; Michael Ronk; Tracy Bostick
Journal:  Int J Anal Chem       Date:  2008-12-17       Impact factor: 1.885

Review 2.  Clinical pharmacology of artemisinin-based combination therapies.

Authors:  Polina I German; Francesca T Aweeka
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.